Barclays’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,456
Closed -$67K 6750
2016
Q3
$67K Sell
1,456
-1,808
-55% -$76.3K ﹤0.01% 4799
2016
Q2
$111K Buy
+3,264
New +$102K ﹤0.01% 4335

Other funds holding NGVT

Barclays's NGVT Position: Q2 2026 in Review

Barclays reduced its Ingevity (NGVT) stake by 11% in Q2 2026, selling an estimated $74.7K and leaving 8,186 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

Barclays first reported a position in NGVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $6.54M in Q3 2018. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Barclays held 8,186 shares of Ingevity worth $611K as of Q2 2026.
  • Barclays sold 1,038 Ingevity shares in Q2 2026, an estimated $74.7K.
  • Ingevity made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3103 holding.
  • Barclays first reported a position in Ingevity in Q2 2016 and has held it in 41 quarters since.
  • Barclays's Ingevity position peaked at $6.54M in Q3 2018.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.